| Pharmaceutical Information |
| Drug Name |
Ethionamide |
| Drug ID |
BADD_D00845 |
| Description |
A second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. (From Smith and Reynard, Textbook of Pharmacology, 1992, p868) |
| Indications and Usage |
For use in the treatment of pulmonary and extrapulmonary tuberculosis when other antitubercular drugs have failed. |
| Marketing Status |
approved |
| ATC Code |
J04AD03 |
| DrugBank ID |
DB00609
|
| KEGG ID |
D00591
|
| MeSH ID |
D005000
|
| PubChem ID |
2761171
|
| TTD Drug ID |
D0P0HB
|
| NDC Product Code |
0008-4117 |
| UNII |
OAY8ORS3CQ
|
| Synonyms |
Ethionamide | Ethioniamide | Amidazine | Trecator | Trecator-SC | Trecator SC |
|
| Chemical Information |
| Molecular Formula |
C8H10N2S |
| CAS Registry Number |
536-33-4 |
| SMILES |
CCC1=NC=CC(=C1)C(=S)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
